IBOV 183,827.59 ▲ 0.46% IPSA 11,055.91 ▼ 0.73% IPC MEX 64,944.41 ▼ 0.07% MERVAL 2,782,561 ▼ 0.59% COLCAP 2,558.92 ▼ 0.79% BVL PERÚ 60,220.45 ▲ 0.32% USD/BRL5.20▼ 0.43% USD/MXN18.03▲ 0.20% USD/CLP972.08▲ 0.38% USD/COP3,323▲ 0.62% USD/PEN3.44▼ 0.05% USD/ARS1,524▼ 0.05% USD/UYU40.27▲ 3.67% USD/PYG5,843▲ 2.30% USD/BOB11.96▲ 0.45% USD/DOP59.27▲ 2.75% USD/CRC452.68▲ 2.68% USD/GTQ7.64▲ 3.13% USD/HNL26.87▲ 3.23% USD/NIO36.62▲ 2.65% USD/VES855.74▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.70▲ 1.64% EUR/BRL5.90▲ 0.09% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 183,827.59 ▲ 0.46% IPSA 11,055.91 ▼ 0.73% IPC MEX 64,944.41 ▼ 0.07% MERVAL 2,782,561 ▼ 0.59% COLCAP 2,558.92 ▼ 0.79% BVL PERÚ 60,220.45 ▲ 0.32% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Tuesday, September 29, 2026

Zombie Drug Xylazine Complicates Mexico’s Opioid Crisis

By · April 13, 2024 · 2 min read

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Argentina gives Britain two weeks over Falklands oil”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

In Mexico, health officials have issued a stark warning about Xylazine, a veterinary sedative often dubbed “tranq dope” or “zombie drug.”

This substance is now infiltrating the illicit opioid markets of Tijuana and Mexicali.

These developments echo the troubles experienced in the U.S., where the same substance has significantly worsened the opioid epidemic, particularly in cities like Philadelphia.

Free daily brief — no card needed
Get every Mexico story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

An investigative study spearheaded by Mexico’s National Council for Science and Technology (CONACYT) shed light on this issue.

It analyzed 300 drug residue samples and found Xylazine in 61 instances.

Originally not the focus of the research, which aimed to detect any adulterants, the prominence of Xylazine was both a surprise and a concern.

The presence of Xylazine complicates public health responses significantly.

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →

Unlike standard opioids, Xylazine does not respond to naloxone, the usual antidote for opioid overdoses.

This non-opioid sedative can induce severe respiratory depression.

It can also create serious skin infections, potentially leading to life-threatening conditions or even amputation.

Moreover, the addition of Xylazine to opioids like heroin and fentanyl increases the danger.

This elevates the likelihood of fatal overdoses and complicates treatment efforts for those addicted.

This challenge underscores the need for refined public health strategies.

It also highlights the necessity for robust international collaboration to address the nuances of this expanding crisis.

The situation calls for a reevaluation of current health protocols.

Additionally, there is a need for enhanced international dialogue to effectively tackle the emerging threat of drug adulteration.

It’s imperative for global health leaders to consider these developments in their strategies.

They must navigate the complexities of polydrug use scenarios that now include hazardous adulterants such as Xylazine.

Background

Mexican authorities have reported seizing 1,727 kilograms of fentanyl last year, a similar amount to the seizures in 2022 when nearly 2,086 kilograms were confiscated.

National Guard Commander David Córdova Campos provided these figures, highlighting the ongoing efforts to combat drug-related crimes.

Since Mexican President Andres Manuel Lopez Obrador took office, 7,565 kilograms of fentanyl have been seized, and 1,740 laboratories producing synthetic drugs have been dismantled.

The announcement comes at a time when the significant consumption of fentanyl is causing concerns, particularly in the United States.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.